UroGen Pharma announces inducement RSU grants under Nasdaq Rule 5635(c)(4)
UroGen Pharma Ltd. announced inducement restricted stock units (RSUs) to 19 new employees under Nasdaq Listing Rule 5635(c)(4).
PRINCETON, N.J., Sept.
04, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd.
NASDAQ:URGN, a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new empl…